Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation

American Journal of Pathology

Volumn 187, Issue 4, 2017, Pages 808-818

  Cheng, Shihai ^a,b   Zou, Min ^b   Liu, Qinhui ^b   Kuang, Jiangying ^b   Shen, Jing ^b   Pu, Shiyun ^b   Chen, Lei ^b   Li, Hong ^b   Wu, Tong ^b   Li, Rui ^b   Li, Yanping ^b   Jiang, Wei ^b   Zhang, Zhiyong ^b   He, Jinhan ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS [2 (3, 5 DICHLORPYRIDYLOXY)] BENZENE; 1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ACYL COENZYME A DESATURASE 1; BENZENE DERIVATIVE; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID X RECEPTOR; LIVER X RECEPTOR ALPHA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CELL RECEPTOR; CYP7A1 PROTEIN, MOUSE; LIVER X RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID SYNTHESIS; BIOCHEMICAL COMPOSITION; CHOLESTEROL METABOLISM; CHOLESTEROL STONE; CONTROLLED STUDY; CRYSTALLIZATION; FATTY LIVER; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BILE; BILE CANALICULUS; C57BL MOUSE; GALLBLADDER; GALLSTONES; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BILE; BILE CANALICULI; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FATTY LIVER; GALLBLADDER; GALLSTONES; GENE EXPRESSION REGULATION; LIPOGENESIS; LIVER; LIVER X RECEPTORS; MALE; MICE, INBRED C57BL; PHOSPHOLIPIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 85014528790     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.12.013     Document Type: Article

References (40)

1. 1 Claudel, T., Zollner, G., Wagner, M., Trauner, M., Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochim Biophys Acta 1812 (2011), 867–878.
2. 2 Graf, G.A., Yu, L., Li, W.P., Gerard, R., Tuma, P.L., Cohen, J.C., Hobbs, H.H., ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 278 (2003), 48275–48282.
3. 3 Yu, L., Gupta, S., Xu, F., Liverman, A.D., Moschetta, A., Mangelsdorf, D.J., Repa, J.J., Hobbs, H.H., Cohen, J.C., Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280 (2005), 8742–8747.
4. 4 Smit, J.J., Schinkel, A.H., Oude Elferink, R.P., Groen, A.K., Wagenaar, E., van Deemter, L., Mol, C.A., Ottenhoff, R., van der Lugt, N.M., van Roon, M.A., van der Valk, M.A., Offerhaus, G.J., Berns, A.J., Borst, P., Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 (1993), 451–462.
5. 5 de Aguiar Vallim, T.Q., Tarling, E.J., Ahn, H., Hagey, L.R., Romanoski, C.E., Lee, R.G., Graham, M.J., Motohashi, H., Yamamoto, M., Edwards, P.A., MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab 21 (2015), 298–310.
6. 6 Kerr, T.A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D.W., Schwarz, M., Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2 (2002), 713–720.
7. 7 Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G., Luo, G., Jones, S.A., Goodwin, B., Richardson, J.A., Gerard, R.D., Repa, J.J., Mangelsdorf, D.J., Kliewer, S.A., Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2 (2005), 217–225.
8. 8 Inagaki, T., Moschetta, A., Lee, Y.K., Peng, L., Zhao, G., Downes, M., Yu, R.T., Shelton, J.M., Richardson, J.A., Repa, J.J., Mangelsdorf, D.J., Kliewer, S.A., Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 103 (2006), 3920–3925.
9. 9 Dawson, P.A., Lan, T., Rao, A., Bile acid transporters. J Lipid Res 50 (2009), 2340–2357.
10. 10 He, J., Nishida, S., Xu, M., Makishima, M., Xie, W., PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 140 (2011), 2095–2106.
11. 11 Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., Moore, D.D., The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407 (2000), 920–923.
12. 12 Qatanani, M., Moore, D.D., CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab 6 (2005), 329–339.
13. 13 Sberna, A.L., Assem, M., Gautier, T., Grober, J., Guiu, B., Jeannin, A., Pais de Barros, J.P., Athias, A., Lagrost, L., Masson, D., Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice. J Hepatol 55 (2011), 154–161.
14. 14 Lickteig, A.J., Csanaky, I.L., Pratt-Hyatt, M., Klaassen, C.D., Activation of constitutive androstane receptor (CAR) in mice results in maintained biliary excretion of bile acids despite a marked decrease of bile acids in liver. Toxicol Sci 151 (2016), 403–418.
15. 15 Sberna, A.L., Assem, M., Xiao, R., Ayers, S., Gautier, T., Guiu, B., Deckert, V., Chevriaux, A., Grober, J., Le Guern, N., Pais de Barros, J.P., Moore, D.D., Lagrost, L., Masson, D., Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 31 (2011), 2232–2239.
16. 16 Biddinger, S.B., Haas, J.T., Yu, B.B., Bezy, O., Jing, E., Zhang, W., Unterman, T.G., Carey, M.C., Kahn, C.R., Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 14 (2008), 778–782.
17. 17 Carey, M.C., Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19 (1978), 945–955.
18. 18 Yu, C., Wang, F., Kan, M., Jin, C., Jones, R.B., Weinstein, M., Deng, C.X., McKeehan, W.L., Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 275 (2000), 15482–15489.
19. 19 Folch, J., Lees, M., Sloane Stanley, G.H., A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957), 497–509.
20. 20 Ma, K., Xiao, R., Tseng, H.T., Shan, L., Fu, L., Moore, D.D., Circadian dysregulation disrupts bile acid homeostasis. PLoS One, 4, 2009, e6843.
21. 21 Russell, D.W., The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72 (2003), 137–174.
22. 22 Miyake, J.H., Duong-Polk, X.T., Taylor, J.M., Du, E.Z., Castellani, L.W., Lusis, A.J., Davis, R.A., Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol 22 (2002), 121–126.
23. 23 Assem, M., Schuetz, E.G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R.M., Moore, D.D., Borst, P., Schuetz, J.D., Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279 (2004), 22250–22257.
24. 24 Gao, J., He, J., Zhai, Y., Wada, T., Xie, W., The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284 (2009), 25984–25992.
25. 25 Uppal, H., Zhai, Y., Gangopadhyay, A., Khadem, S., Ren, S., Moser, J.A., Xie, W., Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization. Hepatology 47 (2008), 1331–1342.
26. 26 Wagner, M., Halilbasic, E., Marschall, H.U., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., Trauner, M., CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42 (2005), 420–430.
27. 27 Masson, D., Qatanani, M., Sberna, A.L., Xiao, R., Pais de Barros, J.P., Grober, J., Deckert, V., Athias, A., Gambert, P., Lagrost, L., Moore, D.D., Assem, M., Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice. J Lipid Res 49 (2008), 1682–1691.
28. 28 Langheim, S., Yu, L., von Bergmann, K., Lutjohann, D., Xu, F., Hobbs, H.H., Cohen, J.C., ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J Lipid Res 46 (2005), 1732–1738.
29. 29 Wang, D.Q., Lammert, F., Paigen, B., Carey, M.C., Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology of biliary lipid secretion. J Lipid Res 40 (1999), 2066–2079.
30. 30 Kim, I., Ahn, S.H., Inagaki, T., Choi, M., Ito, S., Guo, G.L., Kliewer, S.A., Gonzalez, F.J., Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48 (2007), 2664–2672.
31. 31 Miao, J., Fang, S., Bae, Y., Kemper, J.K., Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J Biol Chem 281 (2006), 14537–14546.
32. 32 Kir, S., Zhang, Y., Gerard, R.D., Kliewer, S.A., Mangelsdorf, D.J., Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem 287 (2012), 41334–41341.
33. 33 Guo, G.L., Lambert, G., Negishi, M., Ward, J.M., Brewer, H.B. Jr., Kliewer, S.A., Gonzalez, F.J., Sinal, C.J., Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278 (2003), 45062–45071.
34. 34 Maglich, J.M., Lobe, D.C., Moore, J.T., The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res 50 (2009), 439–445.
35. 35 Mennone, A., Soroka, C.J., Cai, S.Y., Harry, K., Adachi, M., Hagey, L., Schuetz, J.D., Boyer, J.L., Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 43 (2006), 1013–1021.
36. 36 Moschetta, A., Bookout, A.L., Mangelsdorf, D.J., Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10 (2004), 1352–1358.
37. 37 Wang, H.H., Afdhal, N.H., Wang, D.Q., Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones. Gastroenterology 127 (2004), 239–249.
38. 38 de Bari, O., Wang, T.Y., Liu, M., Portincasa, P., Wang, D.Q., Estrogen induces two distinct cholesterol crystallization pathways by activating ERalpha and GPR30 in female mice. J Lipid Res 56 (2015), 1691–1700.
39. 39 Uppal, H., Toma, D., Saini, S.P., Ren, S., Jones, T.J., Xie, W., Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice. Hepatology 41 (2005), 168–176.
40. 40 Xiao, L., Xie, X., Zhai, Y., Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism. Adv Drug Deliv Rev 62 (2010), 1316–1321.